Olena Barbash
Impact in
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 12
- Ubiquitin and proteasome pathways 11
- Cancer-related gene regulation 11
- Epigenetics and DNA Methylation 9
- Histone Deacetylase Inhibitors Research 3
- RNA modifications and cancer 3
- Oncology 7
- Cancer-related Molecular Pathways 6
- Co-authors
- Caretha L. Creasy (3 shared papers)Helai P. Mohammad (3 shared papers)J. Alan Diehl (9 shared papers)Anil K. Rustgi (4 shared papers)Peter J. Tummino (6 shared papers)Ryan G. Kruger (6 shared papers)Douglas I. Lin (2 shared papers)David L. Vander Jagt (2 shared papers)
- Journals
- Cancer Research (5 papers)Molecular and Cellular Biology (3 papers)Oncogene (3 papers)Journal of Clinical Oncology (2 papers)Molecular Cell (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Olena Barbash
34 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 2.1k
- Oncology 567
- Cancer Research 260
- Hematology 181
- Cell Biology 273
Countries citing papers authored by Olena Barbash
This map shows the geographic impact of Olena Barbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olena Barbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olena Barbash more than expected).
Fields of papers citing papers by Olena Barbash
This network shows the impact of papers produced by Olena Barbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olena Barbash. The network helps show where Olena Barbash may publish in the future.
Co-authors
The 25 scholars most cited alongside Olena Barbash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 304 | |
| 2 | 2006 | 300 | |
| 3 | 2014 | 287 | |
| 4 | 2013 | 151 | |
| 5 | 2012 | 143 | |
| 6 | 2017 | 140 | |
| 7 | 2013 | 137 | |
| 8 | 2018 | 123 | |
| 9 | 2008 | 118 | |
| 10 | 2005 | 112 | |
| 11 | 2006 | 111 | |
| 12 | 2004 | 101 | |
| 13 | 2008 | 63 | |
| 14 | 2017 | 46 | |
| 15 | 2018 | 45 | |
| 16 | 2011 | 41 | |
| 17 | 2008 | 35 | |
| 18 | 2019 | 29 | |
| 19 | 2013 | 29 | |
| 20 | 2022 | 28 |
About Olena Barbash
Olena Barbash is a scholar working on Molecular Biology, Oncology, Hematology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (12 papers), Ubiquitin and proteasome pathways (11 papers), Cancer-related gene regulation (11 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related Molecular Pathways (6 papers), Multiple Myeloma Research and Treatments (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Molecular Biology (2.1k citations), Oncology (567 citations), Cancer Research (260 citations), Hematology (181 citations) and Cell Biology (273 citations). Olena Barbash has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Caretha L. Creasy, Helai P. Mohammad, J. Alan Diehl, Anil K. Rustgi, Peter J. Tummino, Ryan G. Kruger, Douglas I. Lin, David L. Vander Jagt, Steven F. Abcouwer and Andres J. Klein–Szanto. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Oncogene, Journal of Clinical Oncology and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.